Heron Therapeutics | HRTX - 流动负债

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 70.4M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	流动负债	更改		日
ALKERMES	USD 599.5M		56.06M	2026-03
Alnylam Pharmaceuticals	USD 1.35B		116.87M	2026-03
Amarin	USD 179.64M		14.82M	2026-03
ANI Pharmaceuticals	USD 239.51M		38.6M	2026-03
Anika Therapeutics	USD 20.97M		942K	2026-03
Arrowhead Research	USD 295.22M		52.2M	2026-03
Eisai	JPY 340.25B		47.42B	2026-03
Emergent BioSolutions	USD 651.3M		12.7M	2023-12
GlaxoSmithKline	GBP 22.43B		1.04B	2026-03
Heron Therapeutics	USD 90.52M		5.58M	2026-03
Insmed	USD 361.01M		107.87M	2026-03
Ligand Pharmaceuticals	USD 40.67M		3.22M	2026-03
Merck	USD 26.94B		1.38B	2026-03
Nektar Therapeutics	USD 53.54M		12.8M	2025-12
Neurocrine Biosciences	USD 831.7M		88.3M	2026-03
Omeros	USD 85.5M		2.28M	2025-06
Pacira	USD 108.79M		11.8M	2026-03
Regeneron Pharmaceuticals	USD 5.11B		739.3M	2026-03
Roche Holding	CHF 28B		421M	2025-12
Sangamo BioSciences	USD 47.66M		1.9M	2025-06
Ultragenyx Pharmaceutical	USD 325M		59M	2026-03
Veracyte	USD 56.11M		3.82M	2026-03
Vertex Pharmaceuticals	USD 3.88B		19.4M	2026-03